Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta …

L Martinez, O Cords, Q Liu… - The Lancet Global …, 2022 - thelancet.com
Background BCG vaccines are given to more than 100 million children every year, but there
is considerable debate regarding the effectiveness of BCG vaccination in preventing …

100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19

N Lobo, NA Brooks, AR Zlotta, JD Cirillo… - Nature Reviews …, 2021 - nature.com
Abstract Bacillus Calmette–Guérin (BCG) is the most widely used vaccine worldwide and
has been used to prevent tuberculosis for a century. BCG also stimulates an anti-tumour …

Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study

A Miller, MJ Reandelar, K Fasciglione, V Roumenova… - MedRxiv, 2020 - medrxiv.org
COVID-19 has spread to most countries in the world. Puzzlingly, the impact of the disease is
different in different countries. These differences are attributed to differences in cultural …

BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers

MN Rivas, JE Ebinger, M Wu, N Sun… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused more than 1 million deaths worldwide; thus, there is an urgent need to develop …

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

P Mangtani, I Abubakar, C Ariti… - Clinical infectious …, 2014 - academic.oup.com
Background. Randomized trials assessing BCG vaccine protection against tuberculosis
have widely varying results, for reasons that are not well understood. Methods. We …

Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19

MK Berg, Q Yu, CE Salvador, I Melani, S Kitayama - Science advances, 2020 - science.org
Bacillus Calmette-Guérin (BCG) vaccination may reduce the risk of a range of infectious
diseases, and if so, it could protect against coronavirus disease 2019 (COVID-19). Here, we …

What have we learnt about BCG vaccination in the last 20 years?

HM Dockrell, SG Smith - Frontiers in immunology, 2017 - frontiersin.org
A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which
include genetically modified mycobacteria, mycobacterial antigens delivered by viral …

The status of tuberculosis vaccine development

LK Schrager, J Vekemens, N Drager… - The Lancet Infectious …, 2020 - thelancet.com
Tuberculosis represents the leading global cause of death from an infectious agent.
Controlling the tuberculosis epidemic thus represents an urgent global public health priority …

[PDF][PDF] History of BCG vaccine.

S Luca, T Mihaescu - Maedica, 2013 - maedica.ro
Tuberculosis (TB) is still responsible for 2 million deaths every year despite being a treatable
airborne infectious disease.“Consumption “and “Phthisis “were terms historically used to …

[HTML][HTML] Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes

DL Faustman, A Lee, ER Hostetter, A Aristarkhova… - Cell Reports …, 2022 - cell.com
There is a need for safe and effective platform vaccines to protect against coronavirus
disease 2019 (COVID-19) and other infectious diseases. In this randomized, double …